Weight loss drugs can halve heart patients’ risk of early death, study finds The Guardian
Weight loss jabs could halve risk of death in heart patients, study finds The Telegraph
Weight loss jabs could keep heart failure patients out of hospital The Independent
Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease PR Newswire
Weight loss drugs may reduce risk of early death by 42%, study shows GB News